abstract |
The disclosure relates to a compound having Formula (I′): n nandn nin particular, Compound I-126:n n nwhich modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role. |